Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model

PURPOSE: Small molecule inhibitors have revolutionized treatment of certain genomically-defined solid cancers. Despite breakthroughs in treating systemic disease, central nervous system (CNS) metastatic progression is common, and advancements in treating CNS malignancies remain sparse. By improving...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Juthani, Rupa, Madajewski, Brian, Yoo, Barney, Zhang, Li, Chen, Pei-Ming, Chen, Feng, Turker, Melik Z., Ma, Kai, Overholtzer, Michael, Longo, Valerie A., Carlin, Sean, Aragon-Sanabria, Virginia, Huse, Jason, Gonen, Mithat, Zanzonico, Pat, Rudin, Charles M., Wiesner, Ulrich, Bradbury, Michelle S., Brennan, Cameron W.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942644/
https://ncbi.nlm.nih.gov/pubmed/31515460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1834
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars